Botulinum Toxin Type A 300 units Powder for solution for injection

DRUG3 trials

Sponsors

Ipsen Innovation, Hospital Universitario de Burgos

Conditions

Chronic anal fissureChronic migraineEpisodic Migraine

Phase 3

A Phase III, Randomised, Double-blind, Placebo-controlled, Multicenter, Parallel-group Study with Extension Phase to Evaluate the Efficacy and Safety of Dysport for the Prevention of Episodic Migraine in Adult Participants

Active, not recruitingCTIS2023-504839-40-00

Ipsen InnovationEpisodic Migraine

Start: 2024-03-18Target: 610Updated: 2025-04-28

A Phase III, Randomised, Double-blind, Placebo-controlled, Multicenter, Parallel-group Study with Extension Phase to Evaluate the Efficacy and Safety of Dysport for the Prevention of Chronic Migraine in Adult Participants

Active, not recruitingCTIS2023-504827-17-00

Ipsen InnovationChronic migraine

Start: 2024-03-18Target: 625Updated: 2025-10-16

Phase 4

Treatment of Chronic Anal Fissure with Ultrasound-Guided Inter-Sphincteric Injections of Botulinum Toxin A

Not yet recruitingCTIS2025-520748-13-01

Hospital Universitario de BurgosChronic anal fissure

Target: 50Updated: 2025-01-22